The BRCA1 tumor suppressor has been implicated in a diverse spectrum of cellular processes, including tran-scriptional regulation, DNA repair, and cell cycle check-point control. CtIP was recently identified as a protein that associates with BRCA1 and two other nuclear fac-tors, CtBP1 and Rb1. To understand the functions of CtIP, we have evaluated its biological properties with respect to those of BRCA1. Our results show that CtIP, like its associated factors, is predominantly a nuclear protein. A subset of the endogenous pool of CtIP polypeptides exists in a protein complex that includes both BRCA1 and the BRCA1-associated RING domain protein (BARD1). At the protein level, CtIP expression varies with cell cycle progression in a pattern ide...
Protecting stalled DNA replication forks from degradation by promiscuous nucleases is essential to p...
SummaryDNA-end resection is a highly regulated and critical step in the response and repair of DNA d...
Studies of factors contributed to the development of hereditary breast and ovary cancers lead to the...
Familial cases of breast and ovarian cancer are often attributed to germline mutations of the BRCA1 ...
CtIP is a transcriptional co-regulator that binds a num-ber of proteins involved in cell cycle contr...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
BRCA1 is a large multi-domain protein with a pivotal role in maintaining genome stability and cell c...
Human CtIP is best known for its role in DNA end resection to initiate DNA double-strand break repai...
Breast cancer accounts for the highest incidence and mortality rate of all female cancers. Early de...
Breast cancer is one of the leading causes of death worldwide, and therefore, new and improved appro...
Inherited mutations in the BRCA1 gene predispose to a higher risk of breast/ovarian cancer. The BRCA...
Acquired resistance to the antiestrogen tamoxifen constitutes a major clinical challenge in breast c...
BRCA1 is mutated in the germline of 20-40% of women with hereditary susceptibility to breast and ova...
DNA-end resection is a highly regulated and critical step in the response and repair of DNA double-s...
Individuals with mutations in BRCA1 have a high risk of developing breast and ovarian cancer. Althou...
Protecting stalled DNA replication forks from degradation by promiscuous nucleases is essential to p...
SummaryDNA-end resection is a highly regulated and critical step in the response and repair of DNA d...
Studies of factors contributed to the development of hereditary breast and ovary cancers lead to the...
Familial cases of breast and ovarian cancer are often attributed to germline mutations of the BRCA1 ...
CtIP is a transcriptional co-regulator that binds a num-ber of proteins involved in cell cycle contr...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
BRCA1 is a large multi-domain protein with a pivotal role in maintaining genome stability and cell c...
Human CtIP is best known for its role in DNA end resection to initiate DNA double-strand break repai...
Breast cancer accounts for the highest incidence and mortality rate of all female cancers. Early de...
Breast cancer is one of the leading causes of death worldwide, and therefore, new and improved appro...
Inherited mutations in the BRCA1 gene predispose to a higher risk of breast/ovarian cancer. The BRCA...
Acquired resistance to the antiestrogen tamoxifen constitutes a major clinical challenge in breast c...
BRCA1 is mutated in the germline of 20-40% of women with hereditary susceptibility to breast and ova...
DNA-end resection is a highly regulated and critical step in the response and repair of DNA double-s...
Individuals with mutations in BRCA1 have a high risk of developing breast and ovarian cancer. Althou...
Protecting stalled DNA replication forks from degradation by promiscuous nucleases is essential to p...
SummaryDNA-end resection is a highly regulated and critical step in the response and repair of DNA d...
Studies of factors contributed to the development of hereditary breast and ovary cancers lead to the...